Rita Nanda, MD, is a medical oncologist who specializes in the treatment of breast cancer. She has expertise in the treatment of triple-negative, early onset, hereditary, and locally-advanced breast cancers. Dr. Nanda’s research interests include developing novel treatments that will improve outcomes for women with breast cancer, in particular interest triple-negative disease. She serves as a Principal Investigator for the Translational Breast Cancer Research Consortium (TBCRC), the University of Chicago Phase II Network Breast Cancer Program Team Leader, and as a member of the Breast Program Leadership Committee. Dr. Nanda leads the University of Chicago’s clinical and translational breast cancer research program.
